ANDA 80431, held by Abraxis Pharmaceuticals. Metaraminol Bitartrate.
As of Nov 18, 2026, ANDA 80431 (Metaraminol Bitartrate), held by Abraxis Pharmaceuticals, was first approved by FDA on Sep 22, 1972, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 22, 1972 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metaraminol BitartrateEQ 10MG BASE/ML · injectable;injection | Metaraminol Bitartrate | Discontinued |
| Jan 30, 1990 | Supplement 19Labeling | Approved | None posted |
| Dec 12, 1989 | Supplement 14Labeling | Approved | None posted |
| Nov 15, 1988 | Supplement 15Labeling | Approved | None posted |
| Sep 22, 1972 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters